Skip to site menu Skip to page content

Daily Newsletter

12 February 2025

Daily Newsletter

12 February 2025

Stryker sells US spinal implants business

The US spinal fusion market was worth $5.7 billion in 2024 and is expected to reach $6.7 billion by 2034.

GlobalData Healthcare February 12 2025

Stryker has agreed to sell its US spinal implants business to the Viscogliosi Brothers. The newly formed company will be known as VB Spine. The move is expected to enable its major competitors to strengthen their positions in the spinal fusion market.

Stryker occupies a relatively small portion of the US spinal fusion market, making up 9.1%, and has experienced relatively slow growth since its first introduction. Major players such as Medtronic and Globus Medical cover 37.5% and 23.9% respectively. While Stryker does not cover a large section of the market, companies such as Globus Medical and Medtronic can be expected to use this opportunity to grow their influence towards what was previously Stryker’s section of the space. The US spinal fusion market was worth an estimated $5.7 billion in 2024 and is expected to reach $6.7 billion in 2034 with a compound annual growth rate of 1.64%, according to GlobalData, a leading data and analytics company.

This decision appears to be the logical next step when considering Stryker’s less-than-ideal performance in this market, and in the long term may prove beneficial for Stryker as the company continues to focus on interventional spine products. Stryker’s competitors in this space may look to expand their coverage of the market, which could pose challenges for VB Spine going forward.

The market is expected to continue growing due to increasing incidences of spinal disorders, in combination with advancements in surgical navigation and imaging technologies that allow for better surgical precision and better patient outcomes. The potential patient pool for these types of procedures is also likely to increase because of the ageing population. The limiting factor to this growth is the high cost of treatment; however, as advancements continue in the field, that may become less of a barrier. As the spinal fusion market continues to expand, Stryker’s latest sale of the US spinal implants business poses a significant growth opportunity for the other major players, and we may see moves from those companies as they attempt to strengthen their positions.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close